DYSPORT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug DYSPORT contains one active pharmaceutical ingredient (API):

1	Botulinum type A toxin haemagglutinin complex UNII E211KPY694 - BOTULINUM TOXIN TYPE A
	Botulinum toxin type A is a protein complex derived from Clostridium botulinum. The protein consists of type A neurotoxin and several other proteins. Under physiological conditions it is presumed that the complex dissociates and releases the pure neurotoxin. Intramuscular injection of the neurotoxin complex blocks cholinergic transport at the neuromuscular junction by preventing the release of acetylcholine. The nerve endings of the neuromuscular junction no longer respond to nerve impulses and secretion of the chemotransmitter is prevented (chemical denervation).
	Read more about Botulinum toxin type A

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10981Y, 10982B, 10987G, 10988H, 11006G, 11007H, 11015R, 11022D, 11831Q, 11857C, 12178Y, 12214W
BR	Câmara de Regulação do Mercado de Medicamentos	539200201155412, 539212040000403
CA	Health Products and Food Branch	02387735, 02456117, 02460203
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.634-10-05, 97-MBE-0417
EE	Ravimiamet	1040386, 1074305, 1557907, 1557918
ES	Centro de información online de medicamentos de la AEMPS	61155
FI	Lääkealan turvallisuus- ja kehittämiskeskus	017962, 048623, 481598
FR	Base de données publique des médicaments	60242321, 61717276
GB	Medicines & Healthcare Products Regulatory Agency	185389, 47849
HK	Department of Health Drug Office	36983
IL	מִשְׂרַד הַבְּרִיאוּת	6720, 7955
LT	Valstybinė vaistų kontrolės tarnyba	1018160, 1018161, 1060897, 1060898, 1069679, 1070907, 1078855, 1087895, 1088159, 1092397, 1092398, 1093212, 1093213
MT	Medicines Authority	AA770/13301
NL	Z-Index G-Standaard	14338343, 15861473
NL	Z-Index G-Standaard, PRK	105341, 40916
NZ	Medicines and Medical Devices Safety Authority	16053, 6423
PL	Rejestru Produktów Leczniczych	100201557, 100300638
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65098001
SG	Health Sciences Authority	10954P, 15238P
TN	Direction de la Pharmacie et du Médicament	4243012H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699783790110
US	FDA, National Drug Code	0299-5962, 15054-0500, 15054-0530
ZA	Health Products Regulatory Authority	37/30.4/0683